Jefferies Maintains Buy on Amgen, Raises Price Target to $310
Portfolio Pulse from jenniferd'souza@benzinga.com
Jefferies analyst Michael Yee maintains a 'Buy' rating on Amgen (NASDAQ:AMGN) and raises the price target from $275 to $310.
August 14, 2023 | 12:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst Michael Yee maintains a 'Buy' rating on Amgen and raises the price target from $275 to $310. This could potentially lead to an increase in the stock's price.
The raised price target by Jefferies indicates a positive outlook for Amgen. This could lead to increased investor confidence and potentially an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100